000002667 001__ 2667
000002667 005__ 20200402205523.0
000002667 0247_ $$2pmid$$apmid:19016284
000002667 0247_ $$2DOI$$a10.1002/cmdc.200800273
000002667 0247_ $$2WOS$$aWOS:000261877100004
000002667 0247_ $$2altmetric$$aaltmetric:133065
000002667 037__ $$aPreJuSER-2667
000002667 041__ $$aeng
000002667 082__ $$a540
000002667 084__ $$2WoS$$aChemistry, Medicinal
000002667 084__ $$2WoS$$aPharmacology & Pharmacy
000002667 1001_ $$0P:(DE-HGF)0$$avan Groen, T.$$b0
000002667 245__ $$aA Novel D-enantiomeric Peptide Reduces Alzheimer's Disease Amyloid Plaque Load in Transgenic Mice
000002667 260__ $$aWeinheim [u.a.]$$bWiley-VCH$$c2008
000002667 300__ $$a1848 - 1852
000002667 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article
000002667 3367_ $$2DataCite$$aOutput Types/Journal article
000002667 3367_ $$00$$2EndNote$$aJournal Article
000002667 3367_ $$2BibTeX$$aARTICLE
000002667 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000002667 3367_ $$2DRIVER$$aarticle
000002667 440_0 $$019901$$aChemMedChem$$v3$$x1860-7179$$y12
000002667 500__ $$aThis work has been supported by a grant of the Volkswagen-Stiftung to DIN (1/82 649).
000002667 536__ $$0G:(DE-Juel1)FUEK409$$2G:(DE-HGF)$$aFunktion und Dysfunktion des Nervensystems$$cP33$$x0
000002667 588__ $$aDataset connected to Web of Science, Pubmed
000002667 65320 $$2Author$$aneurochemistry
000002667 65320 $$2Author$$aalzheimer's disease
000002667 65320 $$2Author$$atherapy
000002667 65320 $$2Author$$apeptides
000002667 65320 $$2Author$$aphage display
000002667 650_2 $$2MeSH$$aAlzheimer Disease: pathology
000002667 650_2 $$2MeSH$$aAmino Acid Sequence
000002667 650_2 $$2MeSH$$aAmyloid beta-Peptides: chemistry
000002667 650_2 $$2MeSH$$aAmyloid beta-Peptides: metabolism
000002667 650_2 $$2MeSH$$aAnimals
000002667 650_2 $$2MeSH$$aDisease Models, Animal
000002667 650_2 $$2MeSH$$aMice
000002667 650_2 $$2MeSH$$aMice, Transgenic
000002667 650_2 $$2MeSH$$aOligopeptides: chemistry
000002667 650_2 $$2MeSH$$aOligopeptides: pharmacology
000002667 650_2 $$2MeSH$$aPeptide Library
000002667 650_2 $$2MeSH$$aPeptides: chemistry
000002667 650_2 $$2MeSH$$aPeptides: pharmacology
000002667 650_2 $$2MeSH$$aPlaque, Amyloid: drug effects
000002667 650_2 $$2MeSH$$aSpectrometry, Fluorescence
000002667 650_2 $$2MeSH$$aStereoisomerism
000002667 650_7 $$00$$2NLM Chemicals$$aAmyloid beta-Peptides
000002667 650_7 $$00$$2NLM Chemicals$$aD3 peptide
000002667 650_7 $$00$$2NLM Chemicals$$aOligopeptides
000002667 650_7 $$00$$2NLM Chemicals$$aPeptide Library
000002667 650_7 $$00$$2NLM Chemicals$$aPeptides
000002667 650_7 $$2WoSType$$aJ
000002667 7001_ $$0P:(DE-Juel1)VDB15437$$aWiesehan, K.$$b1$$uFZJ
000002667 7001_ $$0P:(DE-Juel1)VDB65869$$aFunke, S. A.$$b2$$uFZJ
000002667 7001_ $$0P:(DE-HGF)0$$aKadish, I.$$b3
000002667 7001_ $$0P:(DE-HGF)0$$aNagel-Steger, L.$$b4
000002667 7001_ $$0P:(DE-Juel1)132029$$aWillbold, D.$$b5$$uFZJ
000002667 773__ $$0PERI:(DE-600)2209649-8$$a10.1002/cmdc.200800273$$gVol. 3, p. 1848 - 1852$$p1848 - 1852$$q3<1848 - 1852$$tChemMedChem$$v3$$x1860-7179$$y2008
000002667 8567_ $$uhttp://dx.doi.org/10.1002/cmdc.200800273
000002667 909CO $$ooai:juser.fz-juelich.de:2667$$pVDB
000002667 915__ $$0StatID:(DE-HGF)0010$$aJCR/ISI refereed
000002667 9141_ $$y2008
000002667 9131_ $$0G:(DE-Juel1)FUEK409$$aDE-HGF$$bGesundheit$$kP33$$lFunktion und Dysfunktion des Nervensystems$$vFunktion und Dysfunktion des Nervensystems$$x0
000002667 9201_ $$0I:(DE-Juel1)VDB805$$d31.12.2008$$gINB$$kINB-2$$lMolekulare Biophysik$$x0
000002667 970__ $$aVDB:(DE-Juel1)107786
000002667 980__ $$aVDB
000002667 980__ $$aConvertedRecord
000002667 980__ $$ajournal
000002667 980__ $$aI:(DE-Juel1)ISB-2-20090406
000002667 980__ $$aUNRESTRICTED
000002667 980__ $$aI:(DE-Juel1)ICS-6-20110106
000002667 981__ $$aI:(DE-Juel1)IBI-7-20200312
000002667 981__ $$aI:(DE-Juel1)ISB-2-20090406
000002667 981__ $$aI:(DE-Juel1)ICS-6-20110106